1. Bioavailability and pharmacokinetics in man of acipimox, a new antilipolytic and hypolipemic agent;Musatti;J. Int. Med. Res.,1981
2. Molecular identification of nicotinic acid receptor;Soga;Biochem. Biophys. Res. Comm.,2003
3. Inhibition of adenylate cyclase and stimulation of a high affinity GTPase by the antilipolytic agents, nicotinic acid, acipimox and various related compounds;Aktories;Arzneimittelforschung,1983
4. Pronounced blood glucose-lowering effect of the antilipolytic drug acipimox in noninsulin-dependent diabetes mellitus patients during a 3-day intensified treatment period;Worm;J. Clin. Endocrin. Metab.,1994
5. Lipid-lowering drugs;Med. Lett. Drugs Ther.,1985